eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2021
vol. 25
 
Share:
Share:
abstract:
Original paper

Phytic acid potentiates oxaliplatin effects in colorectal cancer induced by 1,2-DMH: the role of miR-224 and miR-200a

Tarek M. Okda
1
,
Mohamed A. Katry
2, 3
,
Noha M. Ragab
4
,
Abdel-Gawad S. Shalkami
5

  1. Department of Biochemistry, Faculty of Pharmacy, Damanhour University, Egypt
  2. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Damanhour University, Egypt
  3. Department of Oral Biology and Diagnostic Sciences, Augusta University, Augusta, USA
  4. Department of Pathology, Medical Research Institute, Alexandria University, Egypt
  5. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Egypt
Contemp Oncol (Pozn) 2021; 25 (2): 118–124
Online publish date: 2021/05/13
View full text Get citation
 
PlumX metrics:
Introduction
The third most frequently diagnosed cancer and one of the highest causes of tumour deaths worldwide is colorectal cancer (CRC). The main objective of this study was to determine the role of microRNA-224 (miR-224) as well as microRNA-200a (miR-200a) in CRC. Phytic acid (PA) is a natural antitumour product that was reported to inhibit CRC and play a vital role as a chemopreventive agent against CRC.

Material and methods
We induced CRC in albino rats using 1,2-dimethylhydrazine (1,2-DMH). The miR-224, miR-200a, and -catenin expressions were determined. ELISAs were performed to investigate Bcl-2 expression, caspase-3 activity, and total tissue antioxidants. Finally, histopathological investigations were performed.

Results
We observed a chemoprotective role of PA. PA has a synergistic effect as an antitumour agent with oxaliplatin in CRC treatment. The miR-224, miR-200a, and -catenin expression, when treated with PA alone or with oxaliplatin, was decreased markedly in comparison with the positive control group. The histopathological investigations of colorectal tissues confirmed our molecular and biochemical findings.

Conclusions
Phytic acid possessed efficient anti-carcinogenic properties alone or with oxaliplatin against 1,2-DMH-induced CRC in rats through pathways of apoptosis, cell proliferation, and antioxidants.

keywords:

CRC, phytic acid, miR-224, miR-200a, oxaliplatin

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.